PTC Therapeutics: EC adopts CHMP negative opinion on Translarna
PTC Therapeutics (PTCT) announced that the European Commission has adopted the opinion of the Committee for Medicinal Products for Human Use of ...
Eli Lilly’s (LLY) Alzheimer’s Drug Is Rejected in Europe Over Safety Fears
A European health committee has rejected Eli Lilly’s Alzheimer’s drug, Kisunla, because of safety concerns about possible ...
The Manila Times5d
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer
CStone Pharmaceuticals ('CStone', HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the ...
Morningstar5d
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer
The European Commission (EC) and the Medicines and Healthcare products Regulatory Agency (MHRA ... and may change due to future developments. Disclaimer: only for communication and scientific ...
Donald Trump plans to tariff a key product imported from Ireland, but the tiny European nation is taking him head-on; here's how
President Trump's proposed tariffs on Irish pharmaceutical imports aim to boost US production but may ultimately harm ...
PharmiWeb20h
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...
The Print8d
EU health regulator clears use of AI tool in fatty liver disease trials
(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool ...
The Manila Times1d
CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress
SUZHOU, China, March 27, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today reported 2024 annual ...
PharmiWeb8d
iOnctura commences randomized Phase II study in metastatic uveal melanoma
Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in the randomized Phase II OCULE-01 study ...
Nasdaq9d
Capricor Therapeutics Announces FDA Acceptance of Biologics License Application for Deramiocel in Duchenne Muscular Dystrophy Cardiomyopathy
Deramiocel has received Orphan Drug and Advanced Therapy Medicinal Product designations from the European Medicines Agency. Disclaimer: This is an AI-generated summary of a press release ...
Santhera Pharmaceuticals Holding AG: Santhera proposes Dr. Melanie Rolli as new member of Board of Directors
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, March 27, 2025 - Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Melanie Rolli as an Independent Director at the upcoming A ...
TipRanks on MSN2d
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial
Neurogene Inc. announced its financial results for the fourth quarter and full year 2024, highlighting significant progress in its NGN-401 Phase 1/2 trial for Rett syndrome. The company remains on ...